Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

doi:10.1053/j.gastro.2020.03.049

. 2020 Jul;159(1):376-377.

doi: 10.1053/j.gastro.2020.03.049. Epub 2020 Mar 29.

Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

Hashem B El-Serag¹, Fasiha Kanwal², Ziding Feng³, Jorge A Marrero⁴, Saira Khaderi⁵, Amit G Singal⁴; Texas Hepatocellular Carcinoma Consortium

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas. Electronic address: hasheme@bcm.edu.
² Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
³ Department of Biostatistics, UT MD Anderson Cancer Center, Houston, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
⁵ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas.

PMID: 32234536
PMCID: PMC8375364
DOI: 10.1053/j.gastro.2020.03.049

Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

Hashem B El-Serag et al. Gastroenterology. 2020 Jul.

. 2020 Jul;159(1):376-377.

doi: 10.1053/j.gastro.2020.03.049. Epub 2020 Mar 29.

Authors

Hashem B El-Serag¹, Fasiha Kanwal², Ziding Feng³, Jorge A Marrero⁴, Saira Khaderi⁵, Amit G Singal⁴; Texas Hepatocellular Carcinoma Consortium

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas. Electronic address: hasheme@bcm.edu.
² Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
³ Department of Biostatistics, UT MD Anderson Cancer Center, Houston, Texas.
⁴ Division of Digestive and Liver Diseases, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
⁵ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas.

PMID: 32234536
PMCID: PMC8375364
DOI: 10.1053/j.gastro.2020.03.049

No abstract available

Keywords: Alcoholic Liver Disease; Cirrhosis; HCV Infection; Hepatocellular Carcinoma; Nonalcoholic Fatty Liver Disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflict of interest to declare.

Cited by

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG, Zhang E, Narasimman M, Rich NE, Waljee AK, Hoshida Y, Yang JD, Reig M, Cabibbo G, Nahon P, Parikh ND, Marrero JA. Singal AG, et al. J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023. Epub 2022 Feb 6. J Hepatol. 2022. PMID: 35139400 Free PMC article.
Global epidemiology of cirrhosis - aetiology, trends and predictions.
Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R. Huang DQ, et al. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36977794 Free PMC article. Review.
Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study.
Hou Y, Yan J, Shi K, Liu X, Gao F, Wu T, Meng P, Zhang M, Jiang Y, Wang X. Hou Y, et al. Onco Targets Ther. 2024 Mar 23;17:215-226. doi: 10.2147/OTT.S444536. eCollection 2024. Onco Targets Ther. 2024. PMID: 38550662 Free PMC article.
CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload.
Harjumäki R, Pridgeon CS, Ingelman-Sundberg M. Harjumäki R, et al. Int J Mol Sci. 2021 Jul 30;22(15):8221. doi: 10.3390/ijms22158221. Int J Mol Sci. 2021. PMID: 34360999 Free PMC article. Review.
Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.
Sanchez JI, Jiao J, Kwan SY, Veillon L, Warmoes MO, Tan L, Odewole M, Rich NE, Wei P, Lorenzi PL, Singal AG, Beretta L. Sanchez JI, et al. Cancer Prev Res (Phila). 2021 Oct;14(10):955-962. doi: 10.1158/1940-6207.CAPR-20-0612. Epub 2021 Jul 12. Cancer Prev Res (Phila). 2021. PMID: 34253566 Free PMC article.

See all "Cited by" articles

References

1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817. - PMC - PubMed
1. Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153(4):996–1005. e1. - PubMed
1. El-Serag HB. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018;155(3):607–9. - PMC - PubMed
1. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, et al.Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. American Journal of Gastroenterology. 2019;114(3):530–2. - PMC - PubMed
1. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812–20. e5. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817. - PMC - PubMed

[2] Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817. - PMC - PubMed

[3] Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153(4):996–1005. e1. - PubMed

[4] Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153(4):996–1005. e1. - PubMed

[5] El-Serag HB. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018;155(3):607–9. - PMC - PubMed

[6] El-Serag HB. Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018;155(3):607–9. - PMC - PubMed

[7] Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, et al.Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. American Journal of Gastroenterology. 2019;114(3):530–2. - PMC - PubMed

[8] Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, et al.Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. American Journal of Gastroenterology. 2019;114(3):530–2. - PMC - PubMed

[9] White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812–20. e5. - PMC - PubMed

[10] White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(4):812–20. e5. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

Affiliations

Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical